RSLS - ReShape Lifesciences Inc.
IEX Last Trade
0.1524
-0.008 -5.446%
Share volume: 699,809
Last Updated: Fri 30 Aug 2024 09:42:54 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$0.16
-0.01
-5.17%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-23 | 2022-08-19 | 2022-11-14 | |
| Total revenue | 2.440 M | 2.892 M | 2.798 M | |
| Cost of revenue | 1.222 M | 1.009 M | 697.000 K | |
| Gross profit | 1.218 M | 1.883 M | 2.101 M | |
| 54.60% | 11.58% | |||
| Operating expenses | 9.618 M | 10.878 M | 7.079 M | |
| Selling general and admin | 8.870 M | 10.117 M | 6.491 M | |
| Research and development | 748.000 K | 761.000 K | 588.000 K | |
| Total expenses | 10.840 M | 11.887 M | 7.776 M | |
| 9.66% | -34.58% | |||
| Operating income | -8.400 M | -8.995 M | -4.978 M | |
| Ebit | -8.400 M | -8.995 M | -4.978 M | |
| Pretax income | -8.372 M | -9.567 M | -12.174 M | |
| 14.27% | 27.25% | |||
| Income tax | -157.000 K | 9.000 K | -363.000 K | |
| Net income basic | -8.215 M | -9.576 M | -11.811 M | |
| -16.57% | -23.34% | |||
| Net income | -8.215 M | -9.576 M | -11.811 M | |
| -16.57% | -23.34% |